Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in Virginia, automatically classified by Maddy, our AI policy reader.

Total bills
4
2026 Regular Session
Top supporter
Holly Seibold
100% support rate
Top opponent
Tim Griffin
3% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in Virginia

Legislators moving healthcare in Virginia
Legislator Party Stance Support rate Decisive votes
Holly Seibold
Holly Seibold House · District 12
D
Strong +
100% 66
Elizabeth Bennett-Parker
Elizabeth Bennett-Parker Senate · District 39
D
Strong +
100% 58
Mike Jones
Mike Jones Senate · District 15
D
Strong +
100% 53
Nicole Cole
Nicole Cole House · District 66
D
Strong +
99% 97
Paul Krizek
Paul Krizek House · District 16
D
Strong +
99% 86
Tim Griffin
Tim Griffin House · District 53
R
Strong −
3% 77
Karen Hamilton
Karen Hamilton House · District 62
R
Strong −
3% 69
Tommy Wright
Tommy Wright House · District 50
R
Strong −
3% 59
Phil Scott
Phil Scott House · District 63
R
Strong −
4% 95
Eric Zehr
Eric Zehr House · District 51
R
Strong −
5% 76
Showing 4 of 4 bills

All healthcare bills

vetoed · Virginia · Senate Apr 12, 2026

SB 536: Medical malpractice information disclosures; report.

Medical malpractice information disclosures; report. Requires insurers who issue medical malpractice liability insurance polices covering health care providers in the Commonwealth to disclose, for the preceding calendar year, information regarding (i) premiums; (ii) claims activity; (iii) claim payments and litigation costs; and (iv) insurer financial condition. The bill further requires every hospital or health system licensed in the Commonwealth that maintains self-insurance, captive insurance, risk retention arrangements, or other retained financial risk for medical malpractice liability to disclose information regarding (a) the numbers of physicians and health care providers covered under the malpractice liability program; (b) claims activity; (c) malpractice expenditures; and (d) the total malpractice liability expenditures for the reporting year. The bill further requires such insurers, hospitals, and health care systems to provide a list of verdicts during the reporting year in medical malpractice actions in which the jury verdict exceeded the medical malpractice limitation on recovery. The bill provides that such disclosures and information be submitted to the Chairs of the House and Senate Committees for Courts of Justice and to the ranking Delegate and Senator of the minority party serving on such Committees on or before September 1, 2026, for the 2025 calendar year and on or before March 31 of each year thereafter for the preceding calendar year.
signed · Virginia · House of Delegates Apr 6, 2026

HB 232: Collaborative agreements; removes registered nurses from list of practitioners, etc.

Collaborative agreements; practitioners; diagnosis. Removes registered nurses from the list of practitioners whose diagnoses may form the basis of drug therapy conducted pursuant to a collaborative agreement between a practitioner and a pharmacist.
passed · Virginia · House of Delegates Mar 3, 2026

HB 393: Firefighters Cancer Screening Grant Program and Fund; established.

Firefighters Cancer Screening Grant Program and Fund established. Creates the Firefighters Cancer Screening Grant Program and Fund to award grants to localities for costs incurred in providing certain cancer detection tests to firefighters. The bill provides that in any year that the amount of funds in the Firefighters Cancer Screening Fund reduces to zero and the Fund does not receive a separate appropriation, the Grant Program and Fund shall expire.
in committee · Virginia · Senate Feb 11, 2026

SB 668: State pharmacy benefits manager; contractual provisions, report.

State pharmacy benefits manager; contractual provisions; report. Requires the Department of Medical Assistance Services' contract with the state pharmacy benefits manager to (i) require that that ingredient-cost reimbursement is based on the national average drug acquisition cost, or if unavailable, the wholesale acquisition cost minus a discount set by the Department, plus a professional dispensing fee, determined by the Department; (ii) require real-time or near real-time transparency in drug costs, rebates collected and paid, dispensing fees paid, administrative fees, and all other charges, fees, costs, and holdbacks, claim denials appeals, and network participation; (iii) prohibit the state pharmacy benefits manager from steering Medicaid recipients to affiliated pharmacies through differential cost-sharing, restrictive network design, or the mandatory use of a mail order pharmacy provider; (iv) require the state pharmacy benefits manager to (a) meet network adequacy standards established by the Department; (b) allow any willing pharmacy to participate in the pharmacy network; (c) verify that all contracted pharmacies are actively accepting Medicaid recipients; (d) submit annual reports containing certain information; (e) disclose to the Department pricing and maximum acquisition cost methodologies; and (f) allow invoice-based or national average drug acquisition cost-based appeals and require an adjustment of rates network-wide when an appeal is upheld; and (v) include enforcement mechanisms and monetary penalties for noncompliance. Additionally, the bill requires Department to annually calculate the savings generated by the use of the state pharmacy benefits manager and to annually increase its dispensing fee by the amount of such savings. The bill requires the Department to annually (1) publish and make available on its website its annual and total savings achieved, the annual and total amount applied to dispensing fees increases, and the updated dispensing fees and (2) report to the General Assembly on the state pharmacy benefits manager's compliance, national average drug acquisition cost compliance, pharmacy reimbursement trends, network adequacy compliance, and dispensing fee sufficiency.